Depression And COVID-19 Vaccines: US FDA Notes ‘Imbalance’ In Novavax Trial For Adolescents

 
• By Derrick Gingery
  
COVID-19 and depression
The FDA also noticed cases of depression reported among adolescents in the Pfizer/BioNTech and Moderna COVID-19 vaccine trials. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet